- Home
- GOSS vs CRSR Comparison
GOSS vs CRSR Comparison
Compare GOSS & CRSR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GOSS | CRSR |
|---|---|---|
| Founded | 2015 | 1994 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Manufacturing |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 615.7M | 723.6M |
| IPO Year | 2018 | 2020 |
Fundamental Metrics
Financial Performance| Metric | GOSS | CRSR |
|---|---|---|
| Price | $0.42 | $5.45 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 7 |
| Target Price | ★ $8.83 | $8.50 |
| AVG Volume (30 Days) | ★ 16.9M | 3.5M |
| Earning Date | 01-01-0001 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 78.81 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $114,701,000.00 | ★ $1,316,379,000.00 |
| Revenue This Year | N/A | $0.51 |
| Revenue Next Year | $6.41 | $5.61 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.33 | $4.48 |
| 52 Week High | $3.87 | $12.35 |
Technical Indicators
Market Signals| Indicator | GOSS | CRSR |
|---|---|---|
| Relative Strength Index (RSI) | 13.82 | 50.18 |
| Support Level | N/A | $5.44 |
| Resistance Level | $1.31 | $6.08 |
| Average True Range (ATR) | 0.17 | 0.48 |
| MACD | -0.18 | 0.06 |
| Stochastic Oscillator | 1.65 | 31.87 |
Price Performance
Historical ComparisonAbout GOSS Gossamer Bio Inc.
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.
About CRSR Corsair Gaming Inc.
Corsair Gaming Inc is engaged in the business of providing high-performance gear for gamers and content creators. The product portfolio includes Cases, Keyboards, Mice, Headsets, Power Supplies, Gaming Computers, Gaming Chairs, Mousepads, and other related products. The company operates in two segments namely, Gamer and Creator peripherals, which is the key revenue-generating segment; and Gaming Components and Systems. Geographically, the group derives revenue from the Americas, Europe and the Middle East, and the Asia Pacific.